(Q39707448)

14 September 2017

Interleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogue (English)

1 reference

14 September 2017

0 references

Masuda N

1

1 reference

14 September 2017

Negoro S

2

1 reference

14 September 2017

Takeda K

3

1 reference

14 September 2017

Kurata N

4

1 reference

14 September 2017

Kuwabara T

5

1 reference

14 September 2017

Kobayashi S

6

1 reference

14 September 2017

Fukuoka M

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

British Journal of Cancer

14 September 2017

1 reference

14 September 2017

78

1 reference

14 September 2017

388-389

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.504

14 September 2017

0 references

cites work

A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063033

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063033

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063033

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063033

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063033

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

14 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9703288

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1998.504

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference

14 September 2017

1 reference